Schroder Investment Management Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $15.2M | Buy |
24,326
+12,256
| +102% | +$8.34M | 0.01% | 598 |
|
|
2026
Q1 | $9.33M | Buy |
12,070
+2,359
| +24% | +$1.81M | 0.01% | 685 |
|
|
2025
Q4 | $7.5M | Sell |
9,711
-16,044
| -62% | -$10.9M | 0.01% | 686 |
|
|
2025
Q3 | $14.5M | Buy |
25,755
+3,750
| +17% | +$2.12M | 0.01% | 595 |
|
|
2025
Q2 | $11.6M | Sell |
22,005
-25,815
| -54% | -$14.4M | 0.01% | 614 |
|
|
2025
Q1 | $30.3M | Sell |
47,820
-33,704
| -41% | -$23.2M | 0.03% | 396 |
|
|
2024
Q4 | $58.1M | Sell |
81,524
-13,477
| -14% | -$11.3M | 0.06% | 269 |
|
|
2024
Q3 | $99.9M | Buy |
95,001
+21,104
| +29% | +$23.5M | 0.1% | 169 |
|
|
2024
Q2 | $77.7M | Sell |
73,897
-7,469
| -9% | -$7.24M | 0.09% | 197 |
|
|
2024
Q1 | $78.3M | Buy |
81,366
+39,022
| +92% | +$37.1M | 0.09% | 193 |
|
|
2023
Q4 | $37.2M | Buy |
42,344
+8,901
| +27% | +$7.33M | 0.05% | 347 |
|
|
2023
Q3 | $27.5M | Sell |
33,443
-14,119
| -30% | -$11.1M | 0.04% | 383 |
|
|
2023
Q2 | $34.2M | Sell |
47,562
-92,897
| -66% | -$71.6M | 0.05% | 356 |
|
|
2023
Q1 | $115M | Sell |
140,459
-21,466
| -13% | -$16.2M | 0.17% | 126 |
|
|
2022
Q4 | $117M | Buy |
161,925
+14,663
| +10% | +$10.8M | 0.19% | 120 |
|
|
2022
Q3 | $101M | Buy |
147,262
+88,074
| +149% | +$55.4M | 0.17% | 129 |
|
|
2022
Q2 | $35.4M | Buy |
59,188
+9,190
| +18% | +$5.97M | 0.05% | 327 |
|
|
2022
Q1 | $34.6M | Buy |
49,998
+21,162
| +73% | +$13.4M | 0.05% | 364 |
|
|
2021
Q4 | $18.2M | Sell |
28,836
-16,298
| -36% | -$10M | 0.02% | 487 |
|
|
2021
Q3 | $27.3M | Buy |
45,134
+18,823
| +72% | +$11.7M | 0.04% | 418 |
|
|
2021
Q2 | $14.7M | Buy |
26,311
+1,762
| +7% | +$893K | 0.02% | 585 |
|
|
2021
Q1 | $11.6M | Sell |
24,549
-1,654
| -6% | -$805K | 0.02% | 624 |
|
|
2020
Q4 | $12.7M | Sell |
26,203
-2,956
| -10% | -$1.6M | 0.02% | 577 |
|
|
2020
Q3 | $16.5M | Buy |
29,159
+14,473
| +99% | +$8.78M | 0.03% | 474 |
|
|
2020
Q2 | $9.16M | Buy |
14,686
+11,320
| +336% | +$6.43M | 0.02% | 584 |
|
|
2020
Q1 | $1.7M | Buy |
3,366
+1,693
| +101% | +$698K | ﹤0.01% | 823 |
|
|
2019
Q4 | $628K | Sell |
1,673
-4,551
| -73% | -$1.53M | ﹤0.01% | 1023 |
|
|
2019
Q3 | $1.7M | Buy |
6,224
+4,614
| +287% | +$1.37M | ﹤0.01% | 911 |
|
|
2019
Q2 | $504K | Buy |
1,610
+805
| +100% | +$268K | ﹤0.01% | 1077 |
|
|
2019
Q1 | $331K | Sell |
805
-23
| -3% | -$9.47K | ﹤0.01% | 1036 |
|
|
2018
Q4 | $309K | Hold |
828
| – | – | ﹤0.01% | 1049 |
|
|
2018
Q3 | $335K | Sell |
828
-26
| -3% | -$9.89K | ﹤0.01% | 1075 |
|
|
2018
Q2 | $292K | Sell |
854
-8,291
| -91% | -$2.59M | ﹤0.01% | 1123 |
|
|
2018
Q1 | $3.15M | Sell |
9,145
-3,993
| -30% | -$1.39M | 0.01% | 789 |
|
|
2017
Q4 | $4.94M | Buy |
13,138
+720
| +6% | +$292K | 0.01% | 776 |
|
|
2017
Q3 | $5.4M | Sell |
12,418
-4,058
| -25% | -$1.93M | 0.01% | 743 |
|
|
2017
Q2 | $8.4M | Buy |
16,476
+5,433
| +49% | +$2.38M | 0.02% | 638 |
|
|
2017
Q1 | $4.26M | Sell |
11,043
-2,625
| -19% | -$973K | 0.01% | 737 |
|
|
2016
Q4 | $5.02M | Sell |
13,668
-2,119
| -13% | -$806K | 0.01% | 717 |
|
|
2016
Q3 | $6.35M | Buy |
15,787
+184
| +1% | +$73.8K | 0.01% | 699 |
|
|
2016
Q2 | $5.45M | Sell |
15,603
-13,824
| -47% | -$5.32M | 0.01% | 713 |
|
|
2016
Q1 | $10.6M | Buy |
29,427
+4,416
| +18% | +$1.82M | 0.02% | 591 |
|
|
2015
Q4 | $13.6M | Buy |
25,011
+13,749
| +122% | +$7.45M | 0.03% | 567 |
|
|
2015
Q3 | $5.24M | Buy |
11,262
+5,300
| +89% | +$2.85M | 0.01% | 734 |
|
|
2015
Q2 | $3.01M | Buy |
5,962
+1,000
| +20% | +$488K | 0.01% | 796 |
|
|
2015
Q1 | $2.25M | Sell |
4,962
-2,700
| -35% | -$1.14M | ﹤0.01% | 844 |
|
|
2014
Q4 | $3.14M | Buy |
7,662
+700
| +10% | +$275K | 0.01% | 839 |
|
|
2014
Q3 | $2.51M | Buy |
6,962
+3,498
| +101% | +$1.17M | ﹤0.01% | 882 |
|
|
2014
Q2 | $978K | Hold |
3,464
| – | – | ﹤0.01% | 984 |
|
|
2014
Q1 | $1.04M | Hold |
3,464
| – | – | ﹤0.01% | 970 |
|
|
2013
Q4 | $953K | Hold |
3,464
| – | – | ﹤0.01% | 1032 |
|
|
2013
Q3 | $1.08M | Hold |
3,464
| – | – | ﹤0.01% | 1005 |
|
|
2013
Q2 | $779K | Buy |
+3,464
| New | +$807K | ﹤0.01% | 1037 |
|
Other funds holding REGN
Schroder Investment Management Group's REGN Position: Q2 2026 in Review
Schroder Investment Management Group increased its Regeneron Pharmaceuticals (REGN) stake by 102% in Q2 2026, buying an estimated $8.34M and bringing the position to 24,326 shares worth $15.2M. The position accounts for 0.01% of the portfolio, ranked #598.
Schroder Investment Management Group first reported a position in REGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $117M in Q4 2022. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Schroder Investment Management Group held 24,326 shares of Regeneron Pharmaceuticals worth $15.2M as of Q2 2026.
- Schroder Investment Management Group bought 12,256 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $8.34M.
- Regeneron Pharmaceuticals made up 0.01% of Schroder Investment Management Group's portfolio in Q2 2026, its #598 holding.
- Schroder Investment Management Group first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- Schroder Investment Management Group's Regeneron Pharmaceuticals position peaked at $117M in Q4 2022.
- 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Schroder Investment Management Group's 13F filing for Q2 2026, filed 13 Aug 2026.